FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313395417> ?p ?o ?g. }

• W4313395417 endingPage "19" @default.
• W4313395417 startingPage "11" @default.
• W4313395417 abstract "Quantitative prediction of the potential for drug–drug interaction (DDI) is essential to guarantee the safety and efficacy of drugs. DDI screening, modeling, and prediction is standard practice in the pharmaceutical industry. This review describes our work on (1) the establishment of a standard framework for determining physiologically based pharmacokinetic (PBPK) model structures and parameters useful for quantitatively analyzing DDIs via hepatic organic anion transporting polypeptides (OATPs). By analyzing clinically observed DDIs involving several statins as substrates, and cyclosporin A and rifampicin as inhibitors, similar in vivo inhibition constants for OATPs by each inhibitor were obtained, regardless of the substrate. (2) We took a PBPK modeling-based approach to define rate-determining processes in hepatic elimination of several OATPs and CYP3A dual substrates using our clinical DDI data with specific inhibitors for OATPs and CYP3A. Essential in vivo parameters (the passive diffusion/active transport ratio in the uptake, and the fraction of intrinsic clearance in the total drug elimination from the hepatocytes) dominating the rate-determining process in hepatic elimination were estimated quantitatively. (3) Finally, using our clinical DDI data with rifampicin, we established a PBPK model for coproporphyrin I (CP-I), which is expected to act as an endogenous substrate (biomarker) supporting the prediction of DDI involving hepatic OATPs. Our PBPK modeling-based approach with several in vitro experiments using CP-I and OATP probe substrates (statins) demonstrated the usefulness of the translation of the effect of an OATP inhibitor on CP-I pharmacokinetics into that on OATP probe substrates in drug discovery and development." @default.
• W4313395417 created "2023-01-06" @default.
• W4313395417 creator A5002342778 @default.
• W4313395417 date "2023-01-01" @default.
• W4313395417 modified "2023-09-26" @default.
• W4313395417 title "Development of Prediction Methods for Drug–Drug Interactions Based on the Construction of Physiologically Based Pharmacokinetic Models for Hepatic OATP Substrate Drugs and Endogenous Substrates" @default.
• W4313395417 cites W1973810935 @default.
• W4313395417 cites W1985330287 @default.
• W4313395417 cites W2010241890 @default.
• W4313395417 cites W2060102878 @default.
• W4313395417 cites W2101656479 @default.
• W4313395417 cites W2137332312 @default.
• W4313395417 cites W2150060563 @default.
• W4313395417 cites W2153118465 @default.
• W4313395417 cites W2164826323 @default.
• W4313395417 cites W2170052837 @default.
• W4313395417 cites W2363404314 @default.
• W4313395417 cites W2502300957 @default.
• W4313395417 cites W2598406479 @default.
• W4313395417 cites W2612267332 @default.
• W4313395417 cites W2613826229 @default.
• W4313395417 cites W2616878580 @default.
• W4313395417 cites W2790889484 @default.
• W4313395417 cites W2799486834 @default.
• W4313395417 cites W2892311631 @default.
• W4313395417 doi "https://doi.org/10.1248/yakushi.22-00145" @default.
• W4313395417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36596534" @default.
• W4313395417 hasPublicationYear "2023" @default.
• W4313395417 type Work @default.
• W4313395417 citedByCount "0" @default.
• W4313395417 crossrefType "journal-article" @default.
• W4313395417 hasAuthorship W4313395417A5002342778 @default.
• W4313395417 hasBestOaLocation W43133954171 @default.
• W4313395417 hasConcept C112705442 @default.
• W4313395417 hasConcept C150903083 @default.
• W4313395417 hasConcept C185592680 @default.
• W4313395417 hasConcept C185867374 @default.
• W4313395417 hasConcept C207001950 @default.
• W4313395417 hasConcept C2780035454 @default.
• W4313395417 hasConcept C71924100 @default.
• W4313395417 hasConcept C86803240 @default.
• W4313395417 hasConcept C98274493 @default.
• W4313395417 hasConceptScore W4313395417C112705442 @default.
• W4313395417 hasConceptScore W4313395417C150903083 @default.
• W4313395417 hasConceptScore W4313395417C185592680 @default.
• W4313395417 hasConceptScore W4313395417C185867374 @default.
• W4313395417 hasConceptScore W4313395417C207001950 @default.
• W4313395417 hasConceptScore W4313395417C2780035454 @default.
• W4313395417 hasConceptScore W4313395417C71924100 @default.
• W4313395417 hasConceptScore W4313395417C86803240 @default.
• W4313395417 hasConceptScore W4313395417C98274493 @default.
• W4313395417 hasIssue "1" @default.
• W4313395417 hasLocation W43133954171 @default.
• W4313395417 hasLocation W43133954172 @default.
• W4313395417 hasOpenAccess W4313395417 @default.
• W4313395417 hasPrimaryLocation W43133954171 @default.
• W4313395417 hasRelatedWork W2049819497 @default.
• W4313395417 hasRelatedWork W2068005011 @default.
• W4313395417 hasRelatedWork W2086209760 @default.
• W4313395417 hasRelatedWork W2293351877 @default.
• W4313395417 hasRelatedWork W2956596586 @default.
• W4313395417 hasRelatedWork W3212117736 @default.
• W4313395417 hasRelatedWork W4206966109 @default.
• W4313395417 hasRelatedWork W4307092588 @default.
• W4313395417 hasRelatedWork W4308352595 @default.
• W4313395417 hasRelatedWork W4309723377 @default.
• W4313395417 hasVolume "143" @default.
• W4313395417 isParatext "false" @default.
• W4313395417 isRetracted "false" @default.
• W4313395417 workType "article" @default.